Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100
NCT ID: NCT03450070
Last Updated: 2019-05-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
121 participants
INTERVENTIONAL
2017-11-15
2017-12-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
50 Human Subject Repeat Insult Patch Test
NCT04498676
HRIPT for Collagen Dressing
NCT06283173
To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products
NCT04007159
Human Repeated Insult Patch Test
NCT03474874
Cumulative Irritation Potential of 828 Ointment
NCT00767455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Panel
Light Therapy Mask Cream
Light Therapy Mask Cream
test panel
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Light Therapy Mask Cream
test panel
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18+ years
* Good health
* Signed and datad Informed Consent
* Signed and dated HIPAA
Exclusion Criteria
* Known allergy or sensitivity to cosmetics or toiletries
* Pre-existing other medical conditions
* Treatment with antibiotics, antihistamines, or corticosteroids within 2 weeks of the test
* Chronic medication which could affect the outcome of the study
* Known pregnant or nursing women
* Cancer diagnosis within the past 5 years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harrison Research Laboratories
Union, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CO- 171028001439-SACT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.